会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
    • 对5-羟色胺和多巴胺受体显示亲和力的苯并咪唑酮衍生物
    • US06586435B2
    • 2003-07-01
    • US09933609
    • 2001-08-21
    • Enzo CeredaLuciano MaiocchiAlessandro BrambillaEttore GiraldoGiovanni Battista Schiavi
    • Enzo CeredaLuciano MaiocchiAlessandro BrambillaEttore GiraldoGiovanni Battista Schiavi
    • A61K31496
    • C07D401/12C07D235/26C07D401/14C07D403/12C07D405/12C07D471/04C07D471/10
    • Compound of formula (I) wherein: R1 is hydrogen or C1-C6-alkyl optionally substituted by C3-C6-cycloylalkyl; R2 and R3 together with the nitrogen form a saturated or unsaturated 5- or 6-membered heterocyclic ring optionally containing nitrogen or oxygen as an additional heteroatom, wherein the heterocyclic ring thereof is substituted by a group selected from phenyl, benzyl, and diphenylmethyl, each optionally mono- or di-substituted by one or two groups selected from CF3, C1-C4-alkyl, C1-C4-alkoxy, phenyl, benzyl, halogen, and OH, or R2 and R3 together with the nitrogen form a saturated or unsaturated 5- or 6-membered heterocyclic ring optionally containing nitrogen or oxygen as an additional heteroatom, the heterocyclic ring thereof linked via a single bond, a methylene-bridge, or spiro-connected to another saturated or unsaturated heterocyclic group containing one or two heteroatoms selected from oxygen and nitrogen, the heterocyclic group being optionally mono- or di-substituted by a group selected from CF3, C1-C4-alkyl, C1-C4-alkoxy, phenyl, benzyl, halogen, ═O, and OH, or R2 and R3 together with the nitrogen form a saturated or unsaturated bi- or tricyclic heterocyclic ring system optionally containing nitrogen or oxygen as an additional heteroatom, the heterocyclic ring system is optionally substituted by a group selected from CF3, C1-C4-alkyl, C1-C4-alkoxy, phenyl, benzyl, halogen, ═O, and OH; and A is C2-C6-alkenylene, their pharmaceutically acceptable salts, their preparation, and their use for therapeutic purposes.
    • 式(I)的化合物其中:R 1是氢或任选地被C 3 -C 6 - 环烷基取代的C 1 -C 6烷基; R 2和R 3与氮一起形成饱和或不饱和的5-或6-元杂环,任选地含有氮或 氧作为另外的杂原子,其中其杂环被选自苯基,苄基和二苯基甲基的基团取代,各自任选被一个或两个选自CF 3,C 1 -C 4 - 烷基,C 1 -C 4烷基的基团单取代或二取代, C 4 - 烷氧基,苯基,苄基,卤素和OH,或R 2和R 3与氮一起形成饱和或不饱和的5-或6-元杂环,任选地含有氮或氧作为另外的杂原子,其杂环通过 单键,亚甲基桥,或与另一个含有一个或两个选自氧和氮的杂原子的饱和或不饱和杂环基螺旋连接,杂环基团任选被一个或二个被gr取代的二取代基 选自CF 3,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基,苯基,苄基,卤素,= O和OH,或R 2和R 3与氮一起形成饱和或不饱和的双环或三环杂环体系, 氮或氧作为另外的杂原子,杂环体系任选被选自CF 3,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基,苯基,苄基,卤素,= O和OH中的基团取代; 且A为C 2 -C 6亚烯基,其药学上可接受的盐,其制备及其用于治疗目的的用途。